COVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease.


Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes.

An infection with coronavirus can run different courses. Some of those affected display no symptoms, whereas in other patients the course of the disease can be so severe that for some it is even fatal. Biomarkers serve as a quantifiable indicator for the presence and severity of an infection. They can be identified and evaluated using a blood sample.

Studies have shown that the following biomarkers in particular play an important role in the prognosis of an infection with COVID-19: D-Dimer and troponin as well as C-reactive protein and the inflammatory marker procalcitonin. Raised D-Dimer levels are associated with deep vein thrombosis or a lung embolism, whereas elevated troponin levels indicate heart damage. Raised inflammatory markers have been identified in patients who have died.

nal von minden GmbH has developed rapid tests for the most important biomarkers which can be carried out onsite. Reliable results are available after just 15 minutes. “The faster important biomarkers are determined, the sooner the correct – and potentially life-saving  – treatment measures can be implemented”, says Roland Meißner, CEO of nal von minden GmbH. If blood samples need to be sent to an external laboratory for testing, hours or even days can be lost.

The biomarker rapid tests are suitable for both hospital emergency rooms and GP practices, where they serve to quickly clarify the health status of a patient infected with coronavirus. Results can immediately be discussed with the patient.

Roland Meißner: “We don’t view our tests as being in competition with laboratories, but rather as a valuable addition since laboratories are already overburdened. In the interests of patients, a decision regarding treatment must be made quickly.”



nal von minden GmbH

Följ nal von minden GmbH

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från nal von minden GmbH

Corona rapid test: Celebrate Christmas together without anyone getting infected15.12.2020 13:57:54 CET | Press release

In many places, uncertainty is now mixed in with the anticipation of Christmas: will Christmas be a “super spreader event” as many politicians are warning? “No”, Roland Meissner, the CEO of nal von minden in Moers, Germany is convinced: “you can protect your relatives as best as possible by getting tested for corona beforehand.” There are also tips to minimize the risk of corona during the actual festivities.

nal von minden plans to produce 80 million rapid corona tests per month20.11.2020 11:43:34 CET | Pressmeddelande

Rapid corona testing is playing an increasingly important role in containing the pandemic everywhere – even though the first vaccines are now in sight. The medical technology company nal von minden GmbH from Moers, Germany, is therefore doubling its production: 40 million rapid antigen tests are already being produced in November. By January, this figure is expected to rise to 80 million – every month!

Combined rapid test for Covid-19 and influenza2.11.2020 09:00:00 CET | Pressmeddelande

Corona numbers are rising, and the next challenge is already in sight: Flu season is beginning. The symptoms can be very similar, but a test can differentiate between influenza and Covid-19.A new combined rapid test can detect coronavirus and influenza viruses simultaneously: The NADAL® COVID-19 Ag+Influenza A/B Test from German medical technology company nal von minden delivers a reliable result in just 15 minutes.

New Covid-19 antigen test: Fast and reliable results in just 15 minutes23.10.2020 16:14:31 CEST | Pressmeddelande

Preventing further spread of the coronavirus and taking pressure off laboratories – it is possible with the NADAL® Covid-19 Antigen Test from Germany. Whether in schools, nursing homes, hospitals, companies, or at the airport or larger events: The result is available in just 15 minutes. The new rapid test from medical technology company nal von minden GmbH is already approved in Europe and is available immediately. The high quality has been repeatedly verified.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum